Yingjie Li

机构：The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University · ORCID：0009-0004-1499-4613

发表论文 110 篇 · 总被引 2329 次 · h-index 23

代表论文

• Tumor‐derived exosomal PD-L1: a new perspective in PD-1/PD-L1 therapy for lung cancer (2024 · Frontiers in Immunology · 被引 28)
• ALS plasma biomarkers reveal neurofilament and pTau correlate with disease onset and progression (2025 · Annals of Clinical and Translational Neurology · 被引 24)
• The new microbiome on the block: challenges and opportunities of using human tumor sequencing data to study microbes (2025 · Nature Methods · 被引 19)
• An Explainable Graph Neural Framework to Identify Cancer‐Associated Intratumoral Microbial Communities (2024 · Advanced Science · 被引 10)
• A Three‐Phase Indirect Electrolysis System for Kilo‐scale Generation of C–S Bond Products (2025 · Chinese Journal of Chemistry · 被引 8)
• The oncogene MYBL2 promotes the malignant phenotype and suppresses apoptosis through hedgehog signaling pathway in clear cell renal cell carcinoma (2024 · Heliyon · 被引 4)